Company news
Ocumetics Technology Corp (TSXV:OTC) news
Ocumetics Technology Corp news releases on 6ix. Latest, Sep 17, 2026: Ocumetics Provides Summary of Group One Patient Clinical Progress
Press releases & updates
Ocumetics Provides Summary of Group One Patient Clinical Progress
September 17, 2026
Ocumetics Announces Initiation of Patient Recruitment for Upcoming Group Two Human Clinical Surgeries
September 8, 2026
Ocumetics Completes Manufacturing of Next Generation Solid State Accommodating Intraocular Lenses for Upcoming Group Two First in Human Clinical Surgeries
August 31, 2026
Ocumetics Announces Completion of Third and Final Tranche of Unit Private Placement
August 24, 2026
Ocumetics Announces Completion of Second Tranche of Unit Private Placement
July 31, 2026
Ocumetics Announces Upsizing of Unit Private Placement
July 30, 2026
Ocumetics Announces Corporate and Operational Update as Positive Six-Month Clinical Results Advance Next Phase of First-in-Human Study
July 9, 2026
Ocumetics Announces Significant Debt Conversion Strengthening Balance Sheet Ahead of Patient Study Milestones
June 2, 2026
Ocumetics Accelerates Toward Group Two First-In-Human Study with Manufacturing Launch of Optimized Accommodating Lens
May 12, 2026
Ocumetics Announces Offering of Units
April 29, 2026
Ocumetics Reports Improvement in Six Month First-in-Human Results Meaningful Improvements in Patient Quality of Life
April 20, 2026
Ocumetics Technology Reports Attendance at ASCRS as Successful First-In-Human Trial Continues, No Material Change
April 14, 2026
Ocumetics to Showcase First-In-human Results with Industry Leaders & Potential Strategic Partners at ASCRS Annual Meeting
April 1, 2026
Ocumetics Technology Corp. Achieves Breakthrough in Next-Generation Accommodating Intraocular Lens Design
March 31, 2026
Ocumetics Announces Scientific Advisory Committee to Support Advancing Clinical and Regulatory Strategy
February 26, 2026
Ocumetics Announces Appointment of Raymond Marks to Board of Directors
February 24, 2026
Ocumetics Announces Forbearance Agreement for $4 Million Secured Convertible Debentures and Provides LIFE Offering Update
February 10, 2026
Ocumetics Reports Positive Three Month First-in-Human Results, Significantly De-Risking Its Accommodating Intraocular Lens Technology
February 3, 2026
Ocumetics Announces Proposed Forbearance Agreement for $4 million Secured Convertible Debentures
January 30, 2026
Ocumetics Announces Transition of Chief Medical Officer Consulting Role
January 9, 2026
Ocumetics Technology Announces Closing of First Tranche of Brokered LIFE Offering Led by Centurion One Capital
January 2, 2026
Ocumetics Technology Announces Amendment to Brokered LIFE Offering Led by Centurion One Capital
December 19, 2025
Ocumetics Announces Optimized Lens Delivery System in Collaboration with Medicel
December 9, 2025
Ocumetics Technology Announces $2.5 Million Brokered LIFE Offering Led by Centurion One Capital
November 25, 2025
Ocumetics Reports Continued Improvement in First Group of Patients. Early Vision Results Surpass Expectations
November 5, 2025
Ocumetics to Present at the Centurion One Capital 3rd Annual Bahamas Summit
October 24, 2025
Ocumetics To Participate in the 2025 Maxim Growth Summit
October 21, 2025
Ocumetics Announces Issuance of Stock Options
October 15, 2025
Ocumetics Webinar - Discussion of One-Month Postoperative Patient Results
October 14, 2025
Ocumetics Reports Encouraging One-Month Postoperative Results
October 8, 2025
Ocumetics Reports Second Successful Surgery Day
September 26, 2025
Ocumetics Completes One-Month Postoperative Examinations - Results Pending
September 16, 2025
Ocumetics Engages The Howard Group to Direct Capital Market & Corporate Digital Communications Programs
September 12, 2025
Ocumetics Webinar - Accommodating Intraocular Lens Update
August 27, 2025
Ocumetics Prepares for a Second Day of Accommodating Intraocular Lens Implantations
August 26, 2025
Ocumetics Achieves Historic First: Accommodating Intraocular Lens Successfully Implanted in Human Patients
August 18, 2025
Ocumetics Achieves Clinical Milestones; Poised for Value-Defining First-in-Human Lens Implantations
August 12, 2025
Ocumetics Begins Patient Recruitment for First-In-Human Clinical Study of Accommodating Intraocular Lens
August 5, 2025
Ocumetics Receives Ethics Committee Approval for First-In-Human Clinical Study of Accommodating Intraocular Lens
July 30, 2025
Ocumetics Announces Completion of First Tranche of Unit Private Placement
July 17, 2025
Ocumetics Completes Staff Training for First-In-Human Clinical Study of Accommodating Intraocular Lens
July 9, 2025
Ocumetics Completes Virtual Site Initiation for First-In-Human Clinical Study of Accommodating Intraocular Lens
June 26, 2025
First-In-Human Study of Accommodating Intraocular Lens Set to Begin June 26, 2025
June 24, 2025
Ocumetics Announces Private Placement
June 4, 2025
Ocumetics Targets June 26, 2025 for Commencement of its First in Human Study
June 3, 2025
Ocumetics Announces Mexico City as Site for its First in Human Study
June 2, 2025
Ocumetics Clinical Study Protocol Submission and Site Initiation on Schedule for Summer 2025
May 22, 2025
Ocumetics Completes Manufacturing of Lenses to be used in First-in-Human Study
May 14, 2025
Ocumetics Announces Lens Design Freeze for First-in-Human Study
May 12, 2025
Ocumetics Achieves Key Milestone: Laboratory Testing Confirms Accommodative Power Target was Successfully Achieved in Preparation for First-in-Human Trials
May 8, 2025